Semin Respir Crit Care Med 2012; 33(04): 413-420
DOI: 10.1055/s-0032-1322411
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cost-Effective Critical Care: Cost Containment and Rationing

Gordon D. Rubenfeld
1   Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada
2   Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
08 August 2012 (online)

Abstract

Rationing occurs whenever the demand for a good or service exceeds its supply. Therefore rationing is an inevitable occurrence in medicine and in critical care where the potential demand for effective medical care will exceed supply. Although there are many strategies to allocate medical resources one that is often considered is based on cost-effectiveness. Cost-effectiveness analysis attempts to estimate the value of individual medical treatments in terms of dollars and outcomes. Allocation of medical treatments based on cost-effectiveness analysis requires valid estimates of both the costs and the effectiveness of treatments as well as some overarching body with the authority to enforce allocation based on these analyses.

Limitations of allocation based on cost-effectiveness analysis in critical care include difficulties in estimating marginal costs of critical care treatments, limited evidence for any treatments with efficacy, and the ethical principle of rescuing identifiable lives in imminent risk of death. The prospect of a pandemic influenza-like infection has stimulated a lot of interest in hypothetical rationing strategies for the intensive care unit, none of which has been tested in actual pandemic scenarios. Given the burden of critical illness and the wide variation in resources a global approach to rationing is untenable. The article concludes with a vision of the future of allocation in critical care.

 
  • References

  • 1 Asch DA, Ubel PA. Rationing by any other name. N Engl J Med 1997; 336 (23) 1668-1671
  • 2 Schroeder SA. Personal reflections on the high cost of American medical care: many causes but few politically sustainable solutions. Arch Intern Med 2011; 171 (8) 722-727
  • 3 Mehlman MJ. The legal implications of health care cost containment: a symposium: health care cost containment and medical technology: a critique of waste theory. Case Western Reserve Law Rev 1986; 36: 778-877
  • 4 Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 1986; 2 (1) 53-63
  • 5 Hébert PC, Wells G, Blajchman MA , et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340 (6) 409-417
  • 6 Takala J, Ruokonen E, Webster NR , et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341 (11) 785-792
  • 7 Rubenfeld GD. Understanding why we agree on the evidence but disagree on the medicine. Respir Care 2001; 46 (12) 1442-1449
  • 8 Kahneman D, Slovic P, Tversky A. Judgment under Uncertainty: Heuristics and Biases. Cambridge; New York: Cambridge University Press; 1987
  • 9 Jonsen AR. Bentham in a box: technology assessment and health care allocation. Law Med Health Care 1986; 14 (3–4) 172-174
  • 10 Alderson P, Schierhout G, Roberts I, Bunn F. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2000; (2) CD000567-CD000567
  • 11 Bodenheimer T. The Oregon Health Plan—lessons for the nation. First of two parts. N Engl J Med 1997; 337 (9) 651-655
  • 12 Tengs TO, Meyer G, Siegel JE, Pliskin JS, Graham JD, Weinstein MC. Oregon's Medicaid ranking and cost-effectiveness: is there any relationship?. Med Decis Making 1996; 16 (2) 99-107
  • 13 Rettig RA. False Hope: Bone Marrow Transplantation for Breast Cancer. Oxford: Oxford University Press; 2007
  • 14 Groeger JS, Strosberg MA, Halpern NA , et al. Descriptive analysis of critical care units in the United States. Crit Care Med 1992; 20 (6) 846-863
  • 15 Hadorn DC. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA 1991; 265 (17) 2218-2225
  • 16 Ubel PA, Richardson J, Menzel P. Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ 2000; 9 (2) 127-136
  • 17 Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term “cost effective” in medicine. N Engl J Med 1986; 314 (4) 253-256
  • 18 Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989; 262 (20) 2879-2886
  • 19 Ely EW, Baker AM, Dunagan DP , et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335 (25) 1864-1869
  • 20 Cook D, Guyatt G, Marshall J , et al; Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338 (12) 791-797
  • 21 Darouiche RO, Raad II, Heard SO , et al; Catheter Study Group. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340 (1) 1-8
  • 22 Ben-Menachem T, McCarthy BD, Fogel R , et al. Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis. Crit Care Med 1996; 24 (2) 338-345
  • 23 Inman KJ, Sibbald WJ, Rutledge FS, Clark BJ. Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA 1993; 269 (9) 1139-1143
  • 24 Morgan A, Daly C, Murawski BJ. Dollar and human costs of intensive care. J Surg Res 1973; 14 (5) 441-448
  • 25 Jegers M, Edbrooke DL, Hibbert CL, Chalfin DB, Burchardi H. Definitions and methods of cost assessment: an intensivist's guide. ESICM section on health research and outcome working group on cost effectiveness. Intensive Care Med 2002; 28 (6) 680-685
  • 26 Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282 (6) 554-560
  • 27 Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160 (3) 976-981
  • 28 Rapoport J, Teres D, Zhao Y, Lemeshow S. Length of stay data as a guide to hospital economic performance for ICU patients. Med Care 2003; 41 (3) 386-397
  • 29 Reinhardt UE. Spending more through ‘cost control:’ our obsessive quest to gut the hospital. Health Aff (Millwood) 1996; 15 (2) 145-154
  • 30 Luce JM, Rubenfeld GD. Can health care costs be reduced by limiting intensive care at the end of life?. Am J Respir Crit Care Med 2002; 165 (6) 750-754
  • 31 Strauss MJ, LoGerfo JP, Yeltatzie JA, Temkin N, Hudson LD. Rationing of intensive care unit services. An everyday occurrence. JAMA 1986; 255 (9) 1143-1146
  • 32 Sinuff T, Kahnamoui K, Cook DJ, Luce JM, Levy MM ; Values Ethics and Rationing in Critical Care Task Force. Rationing critical care beds: a systematic review. Crit Care Med 2004; 32 (7) 1588-1597
  • 33 Ward NS, Teno JM, Curtis JR, Rubenfeld GD, Levy MM. Perceptions of cost constraints, resource limitations, and rationing in United States intensive care units: results of a national survey. Crit Care Med 2008; 36 (2) 471-476
  • 34 Marshall MF, Schwenzer KJ, Orsina M, Fletcher JC, Durbin Jr CG. Influence of political power, medical provincialism, and economic incentives on the rationing of surgical intensive care unit beds. Crit Care Med 1992; 20 (3) 387-394
  • 35 Alexander S. They decide who lives, who dies: medical miracle puts moral burden on small committee. Life 1962; 53: 102-125
  • 36 Indiana University Center for Bioethics. Pandemic Influenza Ethics Toolkit. Ethics guide for health care practitioners: working under conditions of an influenza pandemic: plan, prepare, practice 2009. http://bioethics.iu.edu/programs/other/pandemic/pandemic-influenza-ethics-toolkit/ . Accessed September 20, 2011
  • 37 White DB, Katz MH, Luce JM, Lo B. Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med 2009; 150 (2) 132-138
  • 38 Persad G, Wertheimer A, Emanuel EJ. Principles for allocation of scarce medical interventions. Lancet 2009; 373 (9661) 423-431
  • 39 Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 1996; 125 (8) 625-633
  • 40 Hunt L. 'Death by computer' proposition dismissed. The Independent. August 25, 1994
  • 41 Christian MD, Joynt GM, Hick JL, Colvin J, Danis M, Sprung CL ; European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Chapter 7. Critical care triage. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster. Intensive Care Med 2010; 36 (Suppl. 01) S55-S64
  • 42 Christian MD, Hamielec C, Lazar NM , et al. A retrospective cohort pilot study to evaluate a triage tool for use in a pandemic. Crit Care 2009; 13 (5) R170
  • 43 Committee for Disaster Medicine Reform. http://www.cdmr.org/ . Accessed September 20, 2011
  • 44 Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet 2010; 376 (9749) 1339-1346